NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Greenland Resources Inc. (“Greenland Resources” or the “Company”; Cboe CA: MOLY | FSE: M0LY) is pleased to announce that it will be conducting a non-brokered private placement of up to 6,666,667 units of the Company (the “Units”) at a price of C$1.50 per Unit (the “Offering Price”) for a ...

Webcast and Conference Call To be Held Tuesday, August 12, 2025, 8:30 am ETNEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that it will issue financ ...

WAYNE, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no Food and Drug Administration (FDA)-approved therapies, today announced that Wes Kaupinen, Founder and Chief Executive Officer of Palvella, will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth ...

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- StoneX Group Inc. (NASDAQ: SNEX), a global financial services firm connecting clients to the markets across asset classes and geographies, today announced the successful completion of its acquisition of The Benchmark Company, LLC (“Benchmark”), a leading provider of investment banking, equity research, and institutional sales and trading services. The transaction, originally announced on March 11, 2025, adds a complementary suite of capabilities to StoneX’s existi ...

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –Vancouver, BC, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that Dr. Ahad Armin, PhD, P.Eng has joined the Company’s Technical Advisory Committee. Dr. Armin is ...

CINCINNATI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, announced that its Board of Directors has authorized an initial share repurchase program (“SRP”) for up to $100 million of the Company’s outstanding common stock. This new authorization permits shares of common stock to be repurchased from time to time at management's discretion, through a variety of methods, including a 10b5- ...

July MAUs reach 1.7 million; Treasury contains 2,087 BTCOMAHA, Neb., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus" or “the company”), a leading self-custodial cryptocurrency platform, today announced an update to selected digital asset holdings of Exodus’ corporate treasury, as well as updated user and exchange provider processed volume metrics, as of July 31, 2025:Selected Digital Asset Holdings (Unaudited)Bitcoin (BTC): 2,087 BTC as of July 31, 2025 compared to 2, ...

Core Insights - Neuronetics, Inc. reported total revenue of $38.1 million for the second quarter of 2025, reflecting an 18% adjusted pro forma revenue growth and a 132% increase compared to the same quarter in 2024 [1][6][5] - The company achieved record revenue of $23.0 million from Greenbrook clinics during the quarter, contributing significantly to the overall revenue growth [1][6] - Cash used in operations was reduced to $3.5 million, outperforming the guidance of under $5 million [1][4] Financial Performance - Total revenues for the three months ended June 30, 2025, were $38.1 million, up from $16.5 million in the same period of 2024, primarily due to the acquisition of Greenbrook [5][6] - U.S. clinic revenue was $23.0 million, while international revenue increased by 41% to $452,000 [5][7] - Gross margin decreased to 46.6% from 74.0% year-over-year, mainly due to the inclusion of Greenbrook's clinic business [10] Operational Highlights - The company shipped 41 NeuroStar Advanced Therapy Systems, generating $3.5 million in revenue, although this represented a 13% decrease compared to the previous year [8][6] - U.S. treatment session revenue was $10.8 million, an 8% decrease year-over-year, but a 13% increase on a pro forma basis [9][6] - Neuronetics treated over 209,000 global patients with 7.6 million treatment sessions [6] Management and Strategic Developments - Steven Pfanstiel was appointed as the new Chief Financial Officer, bringing over 20 years of healthcare experience [16] - The company secured an additional $10 million in funding from Perceptive Advisors LLC, extending its liquidity requirements [14] - Neuronetics expects total worldwide revenue for the third quarter of 2025 to be between $37.0 million and $39.0 million, and for the full year 2025, between $149.0 million and $155.0 million [17][18] Future Outlook - The company anticipates gross margin improvement in the second half of 2025, expecting it to be between 48% and 50% [18] - Total operating expenses for 2025 are now projected to be between $100.0 million and $105.0 million, reflecting the integration of Greenbrook [19] - Neuronetics expects to achieve positive cash flow from operations in the fourth quarter of 2025 [20]

Core Insights - Xometry, Inc. reported strong financial performance for Q2 2025, achieving record revenue and significant marketplace gross margin expansion, indicating sustainable long-term growth potential [2][5][6] Financial Highlights - Q2 2025 revenue increased by 23% year-over-year to $163 million, driven by robust marketplace growth [5][7] - Marketplace revenue for Q2 2025 was $148 million, a 26% increase year-over-year [6][7] - Gross profit for Q2 2025 rose 23% year-over-year to $65.2 million, representing a gross margin of 40.1% [5][7] - Adjusted EBITDA improved by $6.6 million year-over-year to $3.9 million, reflecting strong operating leverage [5][6] - The net loss attributable to common stockholders for Q2 2025 was $26.4 million, which included a $16.4 million non-recurring loss on debt extinguishment [6][7] Business Developments - Active Buyers increased by 22% year-over-year, reaching 74,777 as of June 30, 2025 [6][11] - The number of Accounts with Last Twelve-Months Spend of at least $50,000 grew by 15% to 1,653 [6][11] - Xometry EU launched Teamspace, a cloud-based solution to enhance collaboration on projects and custom part orders [6][9] - New AI features were introduced to streamline quoting processes for technical drawings in North America [9] Financial Guidance - For Q3 2025, Xometry expects revenue between $167 million and $169 million, representing 18-19% year-over-year growth [12][16] - Adjusted EBITDA for Q3 2025 is projected to be approximately $4.0 to $5.0 million, an improvement from a loss of $0.6 million in Q3 2024 [12][16] - The full year 2025 marketplace growth outlook has been raised to 23-24% [16]

CHANDLER, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- To better support server OEMs, storage systems, data centers and enterprise customers, Microchip Technology (Nasdaq: MCHP) has launched the Adaptec® SmartRAID 4300 series of NVMe® RAID storage accelerators. The new family is a feature-rich, secure, RAID-enabled, high-performance Software-Defined Storage (SDS) solution for NVMe deployments. The accelerators are especially suited for modern AI data center environments where accelerating access to NVMe storage ...